Who
Rosty Raykov
Other role
Company insider
Files Form 4 as: Chief Executive Officer, Fennec Pharmaceuticals.
In numbers
- Trades disclosed
- 157
- Buys
- 1
- Sells
- 39
- Bought
- $0
- Sold
- $4.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 18 Aug 2010
- Last trade
- 1 Sep 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 1 Sep 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $121K10,000 at $12.11 | filing |
| 1 Sep 2026filed 1 Sep 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $121K10,000 at $12.11 | filing |
| 31 Aug 2026filed 1 Sep 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 31 Aug 2026filed 1 Sep 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 3 Aug 2026filed 4 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $96K10,000 at $9.58 | filing |
| 3 Aug 2026filed 4 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $96K10,000 at $9.58 | filing |
| 31 Jul 2026filed 3 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 31 Jul 2026filed 3 Aug 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $38K15,597 at $2.45 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $100K9,599 at $10.41 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | $38K15,597 at $2.45 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | $38K15,597 at $2.45 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —2,778 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $38K15,597 at $2.45 | filing |
| 1 Jul 2026filed 2 Jul 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $100K9,599 at $10.41 | filing |
| 1 Jun 2026filed 2 Jun 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $38K15,597 at $2.45 | filing |
| 1 Jun 2026filed 2 Jun 2026 | FENC Fennec PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $94K9,747 at $9.62 | filing |
| 1 Jun 2026filed 2 Jun 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | $38K15,597 at $2.45 | filing |
| 1 Jun 2026filed 2 Jun 2026 | FENC Fennec Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | $38K15,597 at $2.45 | filing |
News
Head-To-Head Review: Adherex Technologies (NASDAQ:FENC) versus Jaguar Animal Health (NASDAQ:JAGX)FENC · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Rosty Raykov; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.